跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
PSYLIPAX 50 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG
Approved
STANDARD
PSYLIPAX 50 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG
Exeltis Healthcare S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 6, 2025
Approval ID
fd8fbcd16b541507
Company
Exeltis Healthcare S.L.
Type
Standard
Approval Details
Approval Id
fd8fbcd16b541507
Drug Cima Aemps Name
PSYLIPAX 50 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG
Register Number
90630
Holder Company Name
Exeltis Healthcare S.L.
Marketing Company Name
Exeltis Healthcare S.L.
Authorization Date
2025-10-06
Dosage Form
SUSPENSIÓN INYECTABLE DE LIBERACIÓN PROLONGADA EN JERINGA PRECARGADA
Dose
50 mg
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Exeltis Healthcare S.L.
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 6, 2025
Approval ID
fd8fbcd16b541507
Type
Standard
Back to CIMA-AEMPS Approvals
PSYLIPAX 50 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG - CIMA-AEMPS Drug Approval Details